# FDA Approves RevMed’s Breakthrough Pill for Pancreatic Cancer

https://mins.news/en/item/33323

- Bloomberg News, 2026-08-26 15:30 UTC
- Health
- Original: https://www.bloomberg.com/news/articles/2026-08-26/fda-approves-revmed-s-breakthrough-pill-for-pancreatic-cancer?link_source=ta_bluesky_link&taid=6a8f06848f08580001b6714b

> Revolution Medicines won US regulatory approval for daraxonrasib, its pancreatic cancer drug and the first medicine designed to target one of the disease’s key molecular causes.

## Related coverage

- [US drug agency approves breakthrough pancreatic cancer treatment](https://mins.news/en/item/33642) — BBC News, 2026-08-26
- [FDA approves groundbreaking new drug for pancreatic cancer](https://mins.news/en/video/33476) — NBC News, 2026-08-26
- [US FDA approves Revolution Medicines targeted drug for metastatic pancreatic cancer](https://mins.news/en/item/33406) — CNN, 2026-08-26